1. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Issue 10018 (6th February 2016) Authors: Wang-Gillam, Andrea; Li, Chung-Pin; Bodoky, György; Dean, Andrew; Shan, Yan-Shen; Jameson, Gayle; Macarulla, Teresa; Lee, Kyung-Hun; Cunningham, David; Blanc, Jean F; Hubner, Richard A; Chiu, Chang-Fang; Schwartsmann, Gilberto; Siveke, Jens T; Braiteh, Fadi; Moyo, Victor; Belanger, Bruce; Dhindsa... Journal: Lancet Issue: Volume 387:Issue 10018(2016) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Current standards and future perspectives in adjuvant treatment for biliary tract cancers. (March 2020) Authors: Lamarca, Angela; Edeline, Julien; McNamara, Mairéad G; Hubner, Richard A; Nagino, Masato; Bridgewater, John; Primrose, John; Valle, Juan W Journal: Cancer treatment reviews Issue: Volume 84(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials. (11th May 2019) Authors: Lamarca, Angela; Ross, Paul; Wasan, Harpreet S; Hubner, Richard A; McNamara, Mairéad G; Lopes, Andre; Manoharan, Prakash; Palmer, Daniel; Bridgewater, John; Valle, Juan W Journal: Journal of the National Cancer Institute Issue: Volume 112:Number 2(2020) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Druggable molecular alterations in bile duct cancer: potential and current therapeutic applications in clinical trials. (2nd September 2021) Authors: Bourien, Héloïse; Lamarca, Angela; McNamara, Mairéad G; Hubner, Richard A; Valle, Juan W; Edeline, Julien Journal: Expert opinion on investigational drugs Issue: Volume 30:Number 9(2021) Page Start: 975 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis. (December 2021) Authors: Broadbent, Rachel; Wheatley, Roseanna; Stajer, Sabrina; Jacobs, Timothy; Lamarca, Angela; Hubner, Richard A; Valle, Juan W; Amir, Eitan; McNamara, Mairéad G Journal: Cancer treatment reviews Issue: Volume 101(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sunitinib for advanced pancreatic neuroendocrine tumors. Issue 12 (December 2011) Authors: Hubner, Richard A; Valle, Juan W Journal: Expert review of anticancer therapy Issue: Volume 11:Issue 12(2011) Page Start: 1817 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Should folic acid fortification be mandatory? No. Issue 7606 (14th June 2007) Authors: Hubner, Richard A; Houlston, Richard D; Muir, Kenneth R Journal: BMJ Issue: Volume 334:Issue 7606(2007) Page Start: 1253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prospective observational study of prevalence, assessment and treatment of pancreatic exocrine insufficiency in patients with inoperable pancreatic malignancy (PANcreatic cancer Dietary Assessment (PanDA): a study protocol. Issue 5 (13th May 2021) Authors: Carnie, Lindsay E; Lamarca, Angela; Vaughan, Kate; Kapacee, Zainul Abedin; McCallum, Lynne; Backen, Alison; Barriuso, Jorge; McNamara, Mairéad G; Hubner, Richard A; Abraham, Marc; Valle, Juan W Journal: BMJ open Issue: Volume 11:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Health-related quality of life (HRQoL) in patients (pts) with progressive, poorly differentiated, extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC) enrolled in NET-02: A phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy. Issue 28 (1st October 2022) Authors: Craig, Zoe; Swain, Jayne; Sharma, Rohini; Faluyi, Olusola Olusesan; Wadsley, Jonathan; Morgan, Carys; Wall, Lucy R.; Chau, Ian; Reed, Nicholas Simon; Sarker, Debashis; Margetts, Jane; Krell, Daniel; Cave, Judith; Sharmila, Sothi; Anthoney, Alan; Patel, Alkesh; Lamarca, Angela; Hubner, Richard A; ... Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Use of the Rockwood Clinical Frailty Scale in patients with advanced hepatopancreaticobiliary malignancies. Issue 9 (2nd September 2022) Authors: Shah, Dinakshi; Kapacee, Zainul Abedin; Lamarca, Angela; Hubner, Richard A; Valle, Juan W; McNamara, Mairéad G Journal: Expert review of anticancer therapy Issue: Volume 22:Issue 9(2022) Page Start: 1009 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗